Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Medinger

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Hemasphere|March 17, 2022
External Validation of the Revised Pretransplant Assessment of Mortality Score in Allogeneic Hematopoietic Cell Transplantation: A Cohort StudyNicolas Fattinger, Jan A Roth, Helen Baldomero, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 28, 2017
Fungemia and necrotic lymph node infection with Sporopachydermia cereana in a patient with acute myeloid leukemiaCraig Kingston, Michael Medinger, Florian Banderet-Uglioni, et al.
Ejhaem|September 2, 2022
CB-103: A novel CSL-NICD inhibitor for the treatment of NOTCH-driven T-cell acute lymphoblastic leukemia: A case report of complete clinical response in a patient with relapsed and refractory T-ALLMichael Medinger, Till Junker, Dominik Heim, et al.
Annals of Hematology|August 3, 2016
Anti-thymocyte globulin-induced hyperbilirubinemia in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantationMatyas Ecsedi, Jörg Schmohl, Robert Zeiser, et al.
Haematologica|September 16, 2008
The allele burden of JAK2 mutations remains stable over several years in patients with myeloproliferative disordersAlexandre Theocharides, Jakob R Passweg, Michael Medinger, et al.
Haematologica|February 11, 2017
Long-term observation reveals high-frequency engraftment of human acute myeloid leukemia in immunodeficient miceAnna M Paczulla, Stephan Dirnhofer, Martina Konantz, et al.
Anticancer Research|August 30, 2022
Treosulfan-based Reduced-intensity Allogeneic Hematopoietic Cell Transplantation in Adults With Primary Immunodeficiency: A Case SeriesVera Dalla Via, Anne Stelmes, Mike Recher, et al.
Medical Mycology|December 31, 2020
Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipientsMateja Kraljevic, Nina Khanna, Michael Medinger, et al.
Open Forum Infectious Diseases|July 25, 2020
Optimal Treatment Duration of <i>Pseudomonas aeruginosa</i> Infections in Allogeneic Hematopoietic Cell Transplant RecipientsFlaminia Olearo, Ilona Kronig, Stavroula Masouridi-Levrat, et al.
Swiss Medical Weekly|January 29, 2025
Blastic plasmacytoid dendritic cell neoplasm: a Swiss case series of a very rare disease and a structured review of the literatureRamona Meier-Lienhard, Cosima Suter, Thomas Pabst, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Hemasphere|March 17, 2022
External Validation of the Revised Pretransplant Assessment of Mortality Score in Allogeneic Hematopoietic Cell Transplantation: A Cohort StudyNicolas Fattinger, Jan A Roth, Helen Baldomero, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 28, 2017
Fungemia and necrotic lymph node infection with Sporopachydermia cereana in a patient with acute myeloid leukemiaCraig Kingston, Michael Medinger, Florian Banderet-Uglioni, et al.
Ejhaem|September 2, 2022
CB-103: A novel CSL-NICD inhibitor for the treatment of NOTCH-driven T-cell acute lymphoblastic leukemia: A case report of complete clinical response in a patient with relapsed and refractory T-ALLMichael Medinger, Till Junker, Dominik Heim, et al.
Annals of Hematology|August 3, 2016
Anti-thymocyte globulin-induced hyperbilirubinemia in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantationMatyas Ecsedi, Jörg Schmohl, Robert Zeiser, et al.
Haematologica|September 16, 2008
The allele burden of JAK2 mutations remains stable over several years in patients with myeloproliferative disordersAlexandre Theocharides, Jakob R Passweg, Michael Medinger, et al.
Haematologica|February 11, 2017
Long-term observation reveals high-frequency engraftment of human acute myeloid leukemia in immunodeficient miceAnna M Paczulla, Stephan Dirnhofer, Martina Konantz, et al.
Anticancer Research|August 30, 2022
Treosulfan-based Reduced-intensity Allogeneic Hematopoietic Cell Transplantation in Adults With Primary Immunodeficiency: A Case SeriesVera Dalla Via, Anne Stelmes, Mike Recher, et al.
Medical Mycology|December 31, 2020
Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipientsMateja Kraljevic, Nina Khanna, Michael Medinger, et al.
Open Forum Infectious Diseases|July 25, 2020
Optimal Treatment Duration of <i>Pseudomonas aeruginosa</i> Infections in Allogeneic Hematopoietic Cell Transplant RecipientsFlaminia Olearo, Ilona Kronig, Stavroula Masouridi-Levrat, et al.
Swiss Medical Weekly|January 29, 2025
Blastic plasmacytoid dendritic cell neoplasm: a Swiss case series of a very rare disease and a structured review of the literatureRamona Meier-Lienhard, Cosima Suter, Thomas Pabst, et al.
Pageof 9